Investing.com - Orthopediatrics (NASDAQ: KIDS) reported first quarter EPS of $-0.29, $0.02 worse than the analyst estimate of $-0.27. Revenue for the quarter came in at $37.61M versus the consensus estimate of $37.73M.
Guidance
Orthopediatrics sees FY 2024 revenue of $197.00M-$200.00M versus the analyst consensus of $184.80M.
Orthopediatrics's stock price closed at $26.94. It is down -11.76% in the last 3 months and down -37.44% in the last 12 months.
Orthopediatrics saw 2 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Orthopediatrics's stock price’s past reactions to earnings here.
According to InvestingPro, Orthopediatrics's Financial Health score is "good performance".
Check out Orthopediatrics's recent earnings performance, and Orthopediatrics's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar